News coverage about Merit Medical Systems (NASDAQ:MMSI) has trended somewhat positive on Saturday, according to Accern. The research firm identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Merit Medical Systems earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave media coverage about the medical instruments supplier an impact score of 48.4465521088732 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Several analysts have recently weighed in on MMSI shares. Citigroup Inc downgraded shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating and set a $44.00 price target for the company. in a research note on Monday, August 28th. They noted that the move was a valuation call. Raymond James Financial, Inc. reissued an “outperform” rating and issued a $44.00 price objective on shares of Merit Medical Systems in a research note on Monday, August 28th. UBS Group AG (USA) downgraded shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating in a research note on Monday, August 28th. Craig Hallum reissued a “buy” rating and issued a $50.00 price objective (up previously from $42.00) on shares of Merit Medical Systems in a research note on Thursday, July 27th. Finally, Bank of America Corporation initiated coverage on shares of Merit Medical Systems in a research note on Thursday, July 20th. They issued a “buy” rating and a $44.00 price objective for the company. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $41.65.
Shares of Merit Medical Systems (NASDAQ MMSI) traded up $0.75 during trading hours on Friday, reaching $37.95. 236,063 shares of the company were exchanged, compared to its average volume of 519,490. The company has a market cap of $1.89 billion, a P/E ratio of 29.65, a P/E/G ratio of 2.55 and a beta of 1.20. The company has a quick ratio of 1.43, a current ratio of 2.78 and a debt-to-equity ratio of 0.39.
Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Wednesday, October 25th. The medical instruments supplier reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.02. Merit Medical Systems had a net margin of 4.06% and a return on equity of 9.86%. The company had revenue of $179.30 million during the quarter, compared to the consensus estimate of $181.28 million. During the same quarter in the previous year, the firm posted $0.26 earnings per share. Merit Medical Systems’s revenue for the quarter was up 14.2% compared to the same quarter last year. equities research analysts forecast that Merit Medical Systems will post 1.27 EPS for the current year.
In other Merit Medical Systems news, Director Kent W. Stanger sold 670 shares of Merit Medical Systems stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $42.06, for a total value of $28,180.20. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director A Scott Anderson sold 25,000 shares of Merit Medical Systems stock in a transaction on Monday, August 7th. The stock was sold at an average price of $41.15, for a total transaction of $1,028,750.00. Following the completion of the transaction, the director now directly owns 10,400 shares in the company, valued at $427,960. The disclosure for this sale can be found here. Insiders sold 35,000 shares of company stock worth $1,450,457 over the last ninety days. Corporate insiders own 5.00% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Merit Medical Systems (MMSI) Given Daily Media Sentiment Rating of 0.16” was posted by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://www.com-unik.info/2017/11/04/merit-medical-systems-mmsi-given-daily-media-sentiment-rating-of-0-16.html.
About Merit Medical Systems
Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.
What are top analysts saying about Merit Medical Systems Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Merit Medical Systems Inc. and related companies.